Index
| Measure ID |
Title |
eMeasure ID |
Measure Type |
NQF ID |
High Priority |
Submission Methods |
Risk Adjusted? |
Registry Measure? |
|
156
|
Oncology: Radiation Dose Limits to Normal Tissues
|
|
Process |
0382
|
|
Claims | Registry |
|
|
|
069
|
Hematology: Multiple Myeloma: Treatment with Bisphosphonates
|
|
Process |
0380
|
|
Registry |
|
|
|
070
|
Hematology: Chronic Lymphocytic Leukemia (CLL): Baseline Flow Cytometry
|
|
Process |
0379
|
|
Registry |
|
|
|
068
|
Hematology: Myelodysplastic Syndrome (MDS): Documentation of Iron Stores in Patients Receiving Erythropoietin Therapy
|
|
Process |
0378
|
|
Registry |
|
|
|
067
|
Hematology: Myelodysplastic Syndrome (MDS) and Acute Leukemias: Baseline Cytogenetic Testing Performed on Bone Marrow
|
|
Process |
0377
|
|
Registry |
|
|
|
047
|
Care Plan
|
|
Process |
0326
|
|
Claims | Registry |
|
|
|
021
|
Perioperative Care: Selection of Prophylactic Antibiotic - First OR Second Generation Cephalosporin
|
|
Process |
0268
|
|
Claims | Registry |
|
|
|
023
|
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients)
|
|
Process |
0239
|
|
Claims | Registry |
|
|
|
044
|
Coronary Artery Bypass Graft (CABG): Preoperative Beta-Blocker in Patients with Isolated CABG Surgery
|
|
Process |
0236
|
|
Registry |
|
|
|
457
|
Proportion Admitted to Hospice for less than 3 days
|
|
Outcome |
0216
|
|
Registry |
|
|
|
456
|
Proportion Not Admitted To Hospice
|
|
Process |
0215
|
|
Registry |
|
|
|
455
|
Proportion Admitted to the Intensive Care Unit (ICU) in the Last 30 Days of Life
|
|
Outcome |
0213
|
|
Registry |
|
|
Page 7 of 75